The best indicator for Phillips 66 (PSX)
We backtested 20 indicators across daily, weekly and hourly charts on real Phillips 66 (PSX) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Donchian Midline
On the daily chart, this is the strongest risk-adjusted edge we found for Phillips 66 (PSX) over ~14.1 years — trailing buy-and-hold by 1.7% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Donchian Midline ✓ | Daily | 14.8% | 0.73 | -31.0% | 43.4% | 166 | -1.7% |
| 2 | MACD ✓ | Daily | 12.9% | 0.64 | -41.3% | 43.8% | 137 | -3.6% |
| 3 | EMA-10 Trend ✓ | Daily | 12.0% | 0.61 | -46.9% | 41.0% | 300 | -4.6% |
| 4 | RSI Trend (>50) ✓ | Daily | 11.7% | 0.6 | -38.0% | 41.4% | 191 | -4.8% |
| 5 | Rate of Change ✓ | Daily | 11.5% | 0.6 | -39.8% | 43.6% | 227 | -5.0% |
| 6 | Heikin-Ashi Trend ✓ | Weekly | 10.8% | 0.56 | -41.3% | 46.5% | 129 | -4.9% |
| 7 | EMA-10 Trend ✓ | Weekly | 10.6% | 0.55 | -40.4% | 49.2% | 65 | -5.1% |
| 8 | ADX / DMI ✓ | Daily | 8.1% | 0.51 | -38.1% | 39.3% | 89 | -8.4% |
| 9 | Money Flow Index ✓ | Daily | 8.5% | 0.46 | -71.1% | 81.2% | 16 | -8.1% |
| 10 | Williams %R ✓ | Weekly | 7.4% | 0.46 | -31.6% | 75.0% | 16 | -8.3% |
| 11 | Donchian Breakout | Daily | 7.1% | 0.44 | -38.4% | 48.4% | 62 | -9.4% |
| 12 | RSI Trend (>50) ✓ | Weekly | 7.2% | 0.42 | -49.1% | 45.2% | 42 | -8.5% |
| 13 | Donchian Midline ✓ | Weekly | 7.0% | 0.41 | -38.5% | 48.6% | 37 | -8.7% |
| 14 | EMA 20/50 Cross ✓ | Daily | 6.6% | 0.4 | -42.6% | 42.4% | 33 | -9.9% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Phillips 66 (PSX), Donchian Midline on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.